Loading clinical trials...
Loading clinical trials...
A Multicenter Study to Evaluate the Performance of Automated Retinal Disease Assessment Software for the Detection of More Than Mild Diabetic Retinopathy
Conditions
Interventions
ARDA software application
Locations
13
United States
Midwestern University
Glendale, Arizona, United States
NEA Baptist Clinic
Jonesboro, Arkansas, United States
Catalina Research Institute
Montclair, California, United States
Christie Clinic
Champaign, Illinois, United States
Northwestern University
Chicago, Illinois, United States
MedStar Health Research Institute Baltimore
Baltimore, Maryland, United States
Start Date
September 30, 2021
Primary Completion Date
May 23, 2022
Completion Date
May 23, 2022
Last Updated
June 6, 2022
NCT07351786
NCT03135327
NCT06782997
NCT06787482
NCT05147701
NCT06892353
Lead Sponsor
Verily Life Sciences LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions